$BIIB
BIOGEN INC.

2021 Q2 Form 10-Q Financial Statement

#000087504521000044 Filed on July 22, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $2.775B $3.682B
YoY Change -24.63% 1.79%
Cost Of Revenue $459.7M $411.1M
YoY Change 11.82% -13.69%
Gross Profit $2.315B $3.271B
YoY Change -29.21% 4.14%
Gross Profit Margin 83.43% 88.83%
Selling, General & Admin $637.3M $555.1M
YoY Change 14.81% -5.53%
% of Gross Profit 27.53% 16.97%
Research & Development $585.1M $647.6M
YoY Change -9.65% 33.58%
% of Gross Profit 25.27% 19.8%
Depreciation & Amortization $54.70M $51.30M
YoY Change 6.63% 9.15%
% of Gross Profit 2.36% 1.57%
Operating Expenses $1.222B $1.203B
YoY Change 1.64% 12.15%
Operating Profit $485.7M $1.975B
YoY Change -75.4% 0.95%
Interest Expense $56.40M $66.00M
YoY Change -14.55% 38.36%
% of Operating Profit 11.61% 3.34%
Other Income/Expense, Net $96.40M $63.00M
YoY Change 53.02% -131.91%
Pretax Income $582.1M $2.038B
YoY Change -71.43% 15.87%
Income Tax -$409.1M $446.1M
% Of Pretax Income -70.28% 21.89%
Net Earnings $448.5M $1.542B
YoY Change -70.92% 3.21%
Net Earnings / Revenue 16.16% 41.89%
Basic Earnings Per Share $3.00 $9.60
Diluted Earnings Per Share $2.99 $9.59
COMMON SHARES
Basic Shares Outstanding 149.7M shares 160.6M shares
Diluted Shares Outstanding 150.1M shares 160.9M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.051B $4.328B
YoY Change -29.5% 46.59%
Cash & Equivalents $1.742B $2.385B
Short-Term Investments $1.309B $1.943B
Other Short-Term Assets $767.9M $638.8M
YoY Change 20.21% -34.84%
Inventory $1.255B $952.7M
Prepaid Expenses
Receivables $1.688B $2.134B
Other Receivables $0.00 $0.00
Total Short-Term Assets $7.184B $8.494B
YoY Change -15.42% 7.38%
LONG-TERM ASSETS
Property, Plant & Equipment $3.442B $3.331B
YoY Change 3.35% 8.23%
Goodwill $5.764B $5.751B
YoY Change 0.22% 0.03%
Intangibles $2.385B $3.384B
YoY Change -29.52% -8.08%
Long-Term Investments $3.443B $2.371B
YoY Change 45.22% -8.1%
Other Assets $2.528B $1.483B
YoY Change 70.44% 13.58%
Total Long-Term Assets $17.29B $17.02B
YoY Change 1.58% -7.4%
TOTAL ASSETS
Total Short-Term Assets $7.184B $8.494B
Total Long-Term Assets $17.29B $17.02B
Total Assets $24.47B $25.51B
YoY Change -4.08% -2.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $375.3M $383.9M
YoY Change -2.24% 1.8%
Accrued Expenses $1.525B $1.390B
YoY Change 9.71% 0.29%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $3.347B $3.447B
YoY Change -2.9% 7.36%
LONG-TERM LIABILITIES
Long-Term Debt $7.269B $7.424B
YoY Change -2.09% 24.79%
Other Long-Term Liabilities $1.356B $1.475B
YoY Change -8.07% 8.82%
Total Long-Term Liabilities $1.356B $1.475B
YoY Change -8.07% 8.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.347B $3.447B
Total Long-Term Liabilities $1.356B $1.475B
Total Liabilities $13.26B $14.22B
YoY Change -6.8% 6.63%
SHAREHOLDERS EQUITY
Retained Earnings $13.90B $14.47B
YoY Change -3.91% -10.6%
Common Stock $100.0K $100.0K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.977B $2.977B
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $10.75B $11.31B
YoY Change
Total Liabilities & Shareholders Equity $24.47B $25.51B
YoY Change -4.08% -2.95%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income $448.5M $1.542B
YoY Change -70.92% 3.21%
Depreciation, Depletion And Amortization $54.70M $51.30M
YoY Change 6.63% 9.15%
Cash From Operating Activities $1.227B $1.949B
YoY Change -37.01% -0.79%
INVESTING ACTIVITIES
Capital Expenditures -$71.90M -$105.0M
YoY Change -31.52% -43.82%
Acquisitions
YoY Change
Other Investing Activities -$80.80M -$727.7M
YoY Change -88.9% -1056.24%
Cash From Investing Activities -$152.7M -$832.7M
YoY Change -81.66% 651.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -564.5M -1.313B
YoY Change -57.02% -44.72%
NET CHANGE
Cash From Operating Activities 1.227B 1.949B
Cash From Investing Activities -152.7M -832.7M
Cash From Financing Activities -564.5M -1.313B
Net Change In Cash 510.1M -197.6M
YoY Change -358.15% -62.18%
FREE CASH FLOW
Cash From Operating Activities $1.227B $1.949B
Capital Expenditures -$71.90M -$105.0M
Free Cash Flow $1.299B $2.054B
YoY Change -36.73% -4.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000875045
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
149033443 shares
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0005
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0005
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 USD
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 USD
CY2020Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 USD
CY2021Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-19311
dei Entity Registrant Name
EntityRegistrantName
BIOGEN INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0112644
dei Entity Address Address Line1
EntityAddressAddressLine1
225 Binney Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Cambridge
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02142
dei City Area Code
CityAreaCode
617
dei Local Phone Number
LocalPhoneNumber
679-2000
dei Security12b Title
Security12bTitle
Common Stock, $0.0005 par value
dei Trading Symbol
TradingSymbol
BIIB
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
149033443 shares
CY2021Q2 us-gaap Revenues
Revenues
2775000000.0 USD
CY2020Q2 us-gaap Revenues
Revenues
3681600000 USD
us-gaap Revenues
Revenues
5469000000.0 USD
us-gaap Revenues
Revenues
7215900000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
459700000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
411100000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
937800000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
865500000 USD
CY2021Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
585100000 USD
CY2020Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
647600000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1099300000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1123900000 USD
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
637300000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
555100000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1232300000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1125200000 USD
CY2021Q2 biib Amortization And Impairment Of Acquired Intangible Assets
AmortizationAndImpairmentOfAcquiredIntangibleAssets
604100000 USD
CY2020Q2 biib Amortization And Impairment Of Acquired Intangible Assets
AmortizationAndImpairmentOfAcquiredIntangibleAssets
61500000 USD
biib Amortization And Impairment Of Acquired Intangible Assets
AmortizationAndImpairmentOfAcquiredIntangibleAssets
702200000 USD
biib Amortization And Impairment Of Acquired Intangible Assets
AmortizationAndImpairmentOfAcquiredIntangibleAssets
133000000.0 USD
CY2021Q2 biib Collaborationprofitlosssharing
Collaborationprofitlosssharing
-15200000 USD
CY2020Q2 biib Collaborationprofitlosssharing
Collaborationprofitlosssharing
21800000 USD
biib Collaborationprofitlosssharing
Collaborationprofitlosssharing
53300000 USD
biib Collaborationprofitlosssharing
Collaborationprofitlosssharing
93500000 USD
CY2021Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-300000 USD
CY2020Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-10000000.0 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
33500000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-5500000 USD
CY2021Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
18000000.0 USD
CY2020Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
18000000.0 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
75000000.0 USD
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
2289300000 USD
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
1707100000 USD
us-gaap Costs And Expenses
CostsAndExpenses
4009400000 USD
us-gaap Costs And Expenses
CostsAndExpenses
3421600000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
485700000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1974500000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1459600000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
3794300000 USD
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
96400000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
63000000.0 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-410500000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-57500000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
582100000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2037500000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1049100000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3736800000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-409100000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
446100000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-364900000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
738200000 USD
CY2021Q2 biib Income Loss From Equity Method Investments Net Of Tax
IncomeLossFromEquityMethodInvestmentsNetOfTax
34300000 USD
CY2020Q2 biib Income Loss From Equity Method Investments Net Of Tax
IncomeLossFromEquityMethodInvestmentsNetOfTax
15100000 USD
biib Income Loss From Equity Method Investments Net Of Tax
IncomeLossFromEquityMethodInvestmentsNetOfTax
16100000 USD
biib Income Loss From Equity Method Investments Net Of Tax
IncomeLossFromEquityMethodInvestmentsNetOfTax
400000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
1025500000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
1606500000 USD
us-gaap Profit Loss
ProfitLoss
1430100000 USD
us-gaap Profit Loss
ProfitLoss
2999000000.0 USD
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
577000000.0 USD
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
64400000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
571400000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
57800000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
448500000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1542100000 USD
us-gaap Net Income Loss
NetIncomeLoss
858700000 USD
us-gaap Net Income Loss
NetIncomeLoss
2941200000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.00
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
9.60
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.70
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
17.65
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.99
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
9.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.68
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
17.61
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
149700000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
160600000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
150800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
166700000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
150100000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
160900000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151200000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
167000000.0 shares
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
448500000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1542100000 USD
us-gaap Net Income Loss
NetIncomeLoss
858700000 USD
us-gaap Net Income Loss
NetIncomeLoss
2941200000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-500000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
8700000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1300000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
900000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-11000000.0 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-51200000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
138600000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-17400000 USD
CY2021Q2 us-gaap Translation Adjustment For Net Investment Hedge Net Of Tax Period Increase Decrease
TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease
-2300000 USD
CY2020Q2 us-gaap Translation Adjustment For Net Investment Hedge Net Of Tax Period Increase Decrease
TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease
-6200000 USD
us-gaap Translation Adjustment For Net Investment Hedge Net Of Tax Period Increase Decrease
TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease
20100000 USD
us-gaap Translation Adjustment For Net Investment Hedge Net Of Tax Period Increase Decrease
TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease
16800000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-400000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-100000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-2400000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-900000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
15900000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
16900000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-32600000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-47000000.0 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2500000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-31700000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
127200000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-45800000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
451000000.0 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1510400000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
985900000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2895400000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
576900000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
65500000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
572000000.0 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
59600000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1027900000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1575900000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1557900000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2955000000.0 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1742000000.0 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1331200000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
1308800000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
1278900000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1688000000.0 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1913800000 USD
CY2021Q2 biib Duefromanti Cd20therapeuticprograms
DuefromantiCD20therapeuticprograms
422200000 USD
CY2020Q4 biib Duefromanti Cd20therapeuticprograms
DuefromantiCD20therapeuticprograms
413500000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
1254800000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
1068600000 USD
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
767900000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
881100000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
7183700000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
6887100000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
915100000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
772100000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3442200000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3411500000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
402500000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
433300000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2385000000.0 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3084300000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
5763900000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
5762100000 USD
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1849900000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1369500000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2528100000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2899000000.0 USD
CY2021Q2 us-gaap Assets
Assets
24470400000 USD
CY2020Q4 us-gaap Assets
Assets
24618900000 USD
CY2021Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
230900000 USD
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
142000000.0 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
375300000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
454900000 USD
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2741000000.0 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3145300000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3347200000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3742200000 USD
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
7269200000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
7426200000 USD
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
918900000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1032800000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
363900000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
402000000.0 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1356400000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1329600000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
13255600000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
13932800000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
100000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
100000 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-171800000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-299000000.0 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
13900700000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
13976300000 USD
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
2977100000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2977100000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
10751900000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
10700300000 USD
CY2021Q2 us-gaap Minority Interest
MinorityInterest
462900000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
-14200000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11214800000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10686100000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24470400000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24618900000 USD
us-gaap Profit Loss
ProfitLoss
1430100000 USD
us-gaap Profit Loss
ProfitLoss
2999000000.0 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
219800000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
232800000 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
585900000 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
18000000.0 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
75000000.0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
124100000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
115800000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
3300000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
33500000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-5500000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-622800000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
180200000 USD
us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
-283600000 USD
us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
39700000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
16100000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1600000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-112400000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-83700000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-211500000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
268800000 USD
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
8700000 USD
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-149100000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
193800000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
188200000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-188400000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-441400000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
171500000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
504600000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
97300000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-9900000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1996300000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3415800000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1452700000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
3879900000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
1626900000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
3753900000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
28100000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
164500000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
254700000 USD
us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
0 USD
us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
75000000.0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
37000000.0 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Equity
ProceedsFromSaleOfAvailableForSaleSecuritiesEquity
91200000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Equity
ProceedsFromSaleOfAvailableForSaleSecuritiesEquity
500000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-2000000.0 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
7800000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-217400000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-389800000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1050000000.0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5029100000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
14200000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
19200000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
170000000.0 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
0 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
2967300000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1500000000.0 USD
us-gaap Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
0 USD
us-gaap Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
-3300000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
94800000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-20500000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
19000000.0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1349500000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3558700000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
429400000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-532700000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-18600000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
3900000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1331200000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2913700000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1742000000.0 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2384900000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10663200000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
1025500000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2400000 USD
CY2021Q2 biib Noncontrolling Interest Capital Contribution
NoncontrollingInterestCapitalContribution
5000000.0 USD
CY2021Q2 biib Noncontrolling Interest Increase Decrease Other
NoncontrollingInterestIncreaseDecreaseOther
-100000000.0 USD
CY2021Q2 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
13700000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-800000 USD
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-55800000 USD
CY2021Q2 us-gaap Stockholders Equity Other
StockholdersEquityOther
0 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11214800000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10686100000 USD
us-gaap Profit Loss
ProfitLoss
1430100000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
127800000 USD
biib Noncontrolling Interest Capital Contribution
NoncontrollingInterestCapitalContribution
5100000 USD
biib Noncontrolling Interest Increase Decrease Other
NoncontrollingInterestIncreaseDecreaseOther
-100000000.0 USD
us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
33400000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-47600000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-128400000 USD
us-gaap Stockholders Equity Other
StockholdersEquityOther
-1500000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11214800000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12536900000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
1606500000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-30600000 USD
biib Noncontrolling Interest Increase Decrease Other
NoncontrollingInterestIncreaseDecreaseOther
-75000000.0 USD
CY2020Q2 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
11100000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-300000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-49500000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11289200000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
13339100000 USD
us-gaap Profit Loss
ProfitLoss
2999000000.0 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-44000000.0 USD
biib Noncontrolling Interest Increase Decrease Other
NoncontrollingInterestIncreaseDecreaseOther
-75000000.0 USD
us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
29100000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-48000000.0 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-118800000 USD
us-gaap Stockholders Equity Other
StockholdersEquityOther
-700000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11289200000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
biib Interest In Subsidiary
InterestInSubsidiary
1.000
us-gaap Use Of Estimates
UseOfEstimates
The preparation of our condensed consolidated financial statements requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenue and expense and related disclosure of contingent assets and liabilities. On an ongoing basis we evaluate our estimates, judgments and assumptions. We base our estimates on historical experience and on various other assumptions that we believe are reasonable, the results of which form the basis for making judgments about the carrying values of assets, liabilities and equity and the amount of revenue and expense. Actual results may differ from these estimates.The length of time and full extent to which the COVID-19 pandemic directly or indirectly impacts our business, results of operations and financial condition, including sales, expense, reserves and allowances, manufacturing, clinical trials, research and development costs and employee-related amounts, depends on future developments that are highly uncertain, subject to change and are difficult to predict, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain or treat COVID-19 as well as the economic impact on local, regional, national and international customers and markets. We have made estimates of the impact of the COVID-19 pandemic within our condensed consolidated financial statements and there may be changes to those estimates in future periods.
CY2021Q2 biib Number Of Wholesalers
NumberOfWholesalers
2 wholesaler
biib Number Of Wholesalers
NumberOfWholesalers
2 wholesaler
CY2021Q2 biib Number Of Wholesalers
NumberOfWholesalers
2 wholesaler
biib Number Of Wholesalers
NumberOfWholesalers
2 wholesaler
CY2020Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1276000000.0 USD
biib Current Provisions To Product Revenue Reserves Relating To Sales In Current Year
CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear
1960000000.0 USD
biib Adjustments To Product Revenue Reserves Relating To Sales In Prior Years
AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears
48800000 USD
biib Payments Returns Applied Against Product Revenue Reserves Relating To Current Year
PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear
1182400000 USD
biib Payments Returns Applied Against Product Revenue Reserves Relating To Prior Year
PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear
802500000 USD
CY2021Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1202300000 USD
CY2021Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1202300000 USD
CY2020Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1276000000.0 USD
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
203800000 USD
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
328000000.0 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
314900000 USD
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
723000000.0 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
544500000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
209200000 USD
CY2021Q2 biib Inventorynetcurrentandnoncurrent
Inventorynetcurrentandnoncurrent
1254800000 USD
CY2020Q4 biib Inventorynetcurrentandnoncurrent
Inventorynetcurrentandnoncurrent
1068600000 USD
CY2021Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
7637700000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5252700000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2385000000.0 USD
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
8220800000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5136500000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3084300000 USD
CY2021Q2 biib Amortization And Impairment Of Acquired Intangible Assets
AmortizationAndImpairmentOfAcquiredIntangibleAssets
604100000 USD
biib Amortization And Impairment Of Acquired Intangible Assets
AmortizationAndImpairmentOfAcquiredIntangibleAssets
702200000 USD
CY2020Q2 biib Amortization And Impairment Of Acquired Intangible Assets
AmortizationAndImpairmentOfAcquiredIntangibleAssets
61500000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
biib Amortization And Impairment Of Acquired Intangible Assets
AmortizationAndImpairmentOfAcquiredIntangibleAssets
133000000.0 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
110000000.0 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
215000000.0 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
215000000.0 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
225000000.0 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
220000000.0 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
200000000.0 USD
CY2020Q4 us-gaap Goodwill
Goodwill
5762100000 USD
us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
1800000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
5763900000 USD
CY2021Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 USD
biib Technological And Regulatory Success Probability
TechnologicalAndRegulatorySuccessProbability
0.217
CY2021Q2 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
8140700000 USD
CY2021Q2 us-gaap Notes Payable
NotesPayable
7269200000 USD
CY2020Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
8515900000 USD
CY2020Q4 us-gaap Notes Payable
NotesPayable
7426200000 USD
CY2021Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-300000 USD
CY2020Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-10000000.0 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
33500000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-5500000 USD
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
226300000 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
110300000 USD
CY2021Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
1180200000 USD
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
626900000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2223600000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1400000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1100000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2223900000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2049100000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2300000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
400000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2051000000.0 USD
CY2020Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
1239500000 USD
CY2020Q4 biib Equity Securities Available For Sale Accumulated Gross Unrealized Gain Before Tax
EquitySecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax
749700000 USD
CY2020Q4 biib Equity Securities Available For Sale Accumulated Gross Unrealized Loss Before Tax
EquitySecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax
14900000 USD
CY2020Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
1974300000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
1308800000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1308900000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
1278900000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1278600000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
870900000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
870500000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
722600000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
721300000 USD
CY2021Q2 biib Available For Sale Securities Debt Maturities After Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost
44200000 USD
CY2021Q2 biib Available For Sale Securities Debt Maturities After Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue
44200000 USD
CY2020Q4 biib Available For Sale Securities Debt Maturities After Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost
49500000 USD
CY2020Q4 biib Available For Sale Securities Debt Maturities After Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue
49200000 USD
CY2021Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
2223900000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2223600000 USD
CY2020Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
2051000000.0 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2049100000 USD
biib Average Maturity Of Marketable Securities
AverageMaturityOfMarketableSecurities
P13M
biib Average Maturity Of Marketable Securities
AverageMaturityOfMarketableSecurities
P11M
CY2021Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
633500000 USD
CY2020Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1490600000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1452700000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
3879900000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
100000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
6100000 USD
CY2021Q2 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
4800000 USD
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
300000 USD
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
11800000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
500000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
5200000 USD
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
1200000 USD
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
24300000 USD
CY2021Q2 biib Unrealized Gain Losses On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax
-53700000 USD
CY2021Q2 biib Unrealized Gross Losses On Foreign Currency Derivatives Net Before Tax
UnrealizedGrossLossesOnForeignCurrencyDerivativesNetBeforeTax
67000000.0 USD
CY2021Q2 biib Unrealized Gross Gains On Foreign Currency Derivatives Net Before Tax
UnrealizedGrossGainsOnForeignCurrencyDerivativesNetBeforeTax
13300000 USD
CY2020Q4 biib Unrealized Gain Losses On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax
212500000 USD
CY2021Q2 biib Unrealized Gain Losses On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax
-53700000 USD
us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
12600000 USD
CY2020Q2 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
8300000 USD
us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-5900000 USD
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1880300000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1782300000 USD
CY2021Q2 us-gaap Depreciation
Depreciation
54700000 USD
us-gaap Depreciation
Depreciation
103500000 USD
CY2020Q2 us-gaap Depreciation
Depreciation
51300000 USD
us-gaap Depreciation
Depreciation
99700000 USD
CY2021Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
151800000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
24400000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-299000000.0 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
78200000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
49000000.0 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
127200000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-171800000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-135200000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-3300000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-42500000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-45800000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-181000000.0 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
448500000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1542100000 USD
us-gaap Net Income Loss
NetIncomeLoss
858700000 USD
us-gaap Net Income Loss
NetIncomeLoss
2941200000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
149700000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
160600000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
150800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
166700000 shares
CY2021Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
400000 shares
CY2020Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
300000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
400000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
300000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
150100000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
160900000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151200000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
167000000.0 shares
CY2021Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
59400000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
45500000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
137900000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
121900000 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1700000 USD
CY2020Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1500000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
4300000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
3000000.0 USD
CY2021Q2 biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
57700000 USD
CY2020Q2 biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
44000000.0 USD
biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
133600000 USD
biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
118900000 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
10900000 USD
CY2020Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
7000000.0 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
24900000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
20300000 USD
CY2021Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
59400000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
45500000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
137900000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
121900000 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1700000 USD
CY2020Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1500000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
4300000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
3000000.0 USD
CY2021Q2 biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
57700000 USD
CY2020Q2 biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
44000000.0 USD
biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
133600000 USD
biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
118900000 USD
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.013
CY2020Q2 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.004
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.011
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.005
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.077
CY2020Q2 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.034
us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.091
us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.037
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.029
CY2020Q2 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.010
us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.033
us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.010
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization
-0.008
CY2020Q2 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization
0.002
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization
-0.001
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization
0.002
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0
CY2020Q2 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0.027
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0.015
CY2021Q2 biib Effective Tax Rate Reconciliation Gilt Itax
EffectiveTaxRateReconciliationGILTItax
0.015
CY2020Q2 biib Effective Tax Rate Reconciliation Gilt Itax
EffectiveTaxRateReconciliationGILTItax
0.015
biib Effective Tax Rate Reconciliation Gilt Itax
EffectiveTaxRateReconciliationGILTItax
0.013
biib Effective Tax Rate Reconciliation Gilt Itax
EffectiveTaxRateReconciliationGILTItax
0.011
CY2021Q2 biib Effective Tax Rate Reconciliation Nuer Immune Tax Impacts
EffectiveTaxRateReconciliationNuerImmuneTaxImpacts
-0.831
CY2020Q2 biib Effective Tax Rate Reconciliation Nuer Immune Tax Impacts
EffectiveTaxRateReconciliationNuerImmuneTaxImpacts
-0.002
biib Effective Tax Rate Reconciliation Nuer Immune Tax Impacts
EffectiveTaxRateReconciliationNuerImmuneTaxImpacts
-0.463
biib Effective Tax Rate Reconciliation Nuer Immune Tax Impacts
EffectiveTaxRateReconciliationNuerImmuneTaxImpacts
-0.002
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.004
CY2020Q2 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.007
us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.006
us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.004
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.703
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.219
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.348
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.198
CY2021Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
500000000.0 USD
CY2021Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
875000000.0 USD
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
375000000.0 USD
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
375000000.0 USD
CY2020Q4 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
20000000.0 USD
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
2700000 USD
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
7600000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
5600000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
32000000.0 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
56400000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
66000000.0 USD
us-gaap Interest Expense
InterestExpense
121100000 USD
us-gaap Interest Expense
InterestExpense
110300000 USD
CY2021Q2 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
153900000 USD
CY2020Q2 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
106800000 USD
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-282700000 USD
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
29500000 USD
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-800000 USD
CY2020Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
10400000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-9400000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-8500000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000000.0 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4200000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2900000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-200000 USD
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
96400000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
63000000.0 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-410500000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-57500000 USD
CY2021Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
153900000 USD
CY2021Q2 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
400000 USD
CY2020Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
102900000 USD
CY2020Q2 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-288400000 USD
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
6600000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
42000000.0 USD
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0 USD
CY2021Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
154300000 USD
CY2020Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
102900000 USD
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-281800000 USD
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
42000000.0 USD
CY2021Q2 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
400000 USD
CY2020Q2 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0 USD
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
6600000 USD
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0 USD
CY2021Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
153900000 USD
CY2020Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
102900000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-288400000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
42000000.0 USD
CY2021Q2 biib Collaborationexpensesaccrual
Collaborationexpensesaccrual
383400000 USD
CY2020Q4 biib Collaborationexpensesaccrual
Collaborationexpensesaccrual
389900000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
242500000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
333800000 USD
CY2021Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
240300000 USD
CY2020Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
218500000 USD
CY2021Q2 us-gaap Construction Payable Current And Noncurrent
ConstructionPayableCurrentAndNoncurrent
72400000 USD
CY2020Q4 us-gaap Construction Payable Current And Noncurrent
ConstructionPayableCurrentAndNoncurrent
181500000 USD
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
149600000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
760300000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
791400000 USD
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2741000000.0 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3145300000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1356400000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1329600000 USD
CY2021Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
652700000 USD
CY2020Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
709900000 USD
CY2021Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
500000000.0 USD
CY2021Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
875000000.0 USD
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
375000000.0 USD
CY2021Q2 biib Investment In Biotechnology Companies That Are Determined To Be Unconsolidated Variable Interest Entities
InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities
15200000 USD
CY2020Q4 biib Investment In Biotechnology Companies That Are Determined To Be Unconsolidated Variable Interest Entities
InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities
12800000 USD
CY2020Q4 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
200000000.0 USD

Files In Submission

Name View Source Status
0000875045-21-000044-index-headers.html Edgar Link pending
0000875045-21-000044-index.html Edgar Link pending
0000875045-21-000044.txt Edgar Link pending
0000875045-21-000044-xbrl.zip Edgar Link pending
biib-20210630.htm Edgar Link pending
biib-20210630.xsd Edgar Link pending
biib-20210630_cal.xml Edgar Link unprocessable
biib-20210630_def.xml Edgar Link unprocessable
biib-20210630_g1.jpg Edgar Link pending
biib-20210630_g10.jpg Edgar Link pending
biib-20210630_g11.jpg Edgar Link pending
biib-20210630_g12.jpg Edgar Link pending
biib-20210630_g13.jpg Edgar Link pending
biib-20210630_g14.jpg Edgar Link pending
biib-20210630_g15.jpg Edgar Link pending
biib-20210630_g16.jpg Edgar Link pending
biib-20210630_g17.jpg Edgar Link pending
biib-20210630_g18.jpg Edgar Link pending
biib-20210630_g19.jpg Edgar Link pending
biib-20210630_g2.jpg Edgar Link pending
biib-20210630_g20.jpg Edgar Link pending
biib-20210630_g21.jpg Edgar Link pending
biib-20210630_g3.jpg Edgar Link pending
biib-20210630_g4.jpg Edgar Link pending
biib-20210630_g5.jpg Edgar Link pending
biib-20210630_g6.jpg Edgar Link pending
biib-20210630_g7.jpg Edgar Link pending
biib-20210630_g8.jpg Edgar Link pending
biib-20210630_g9.jpg Edgar Link pending
biib-20210630_htm.xml Edgar Link completed
biib-20210630_lab.xml Edgar Link unprocessable
biib-20210630_pre.xml Edgar Link unprocessable
biib-2021630xex311.htm Edgar Link pending
biib-2021630xex312.htm Edgar Link pending
biib-2021630xex321.htm Edgar Link pending
exhibit101amendedmanagemen.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending